Transactions of the Royal Society of Tropical Medicine and Hygiene · 1996 · 38 citations · 21 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial ResistanceMedical MicrobiologyPharmacogeneticsAntiparasitic Drug ResistanceAntiparasitic PharmacotherapyAntiparasitic ResistanceAntiparasitic TherapyMalariaTropical MedicineAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentDihydrofolate Reductase MutationMalaria ResistancePlasmodium FalciparumPositionTreatment Of Malaria
A nested polymerase chain reaction was used to amplify a fragment of the gene for dihydrofolate reductase of Plasmodium falciparum containing codon 108, where a point mutation, causing a serine to asparagine change, occurs in pyrimethamine resistant parasites. The presence of the mutation was detected by restriction enzyme digestion. Parasites in blood samples collected from asymptomatic children before, and 3 weeks after, treatment with pyrimethamine-sulfadoxine or chlorproguanil-dapsone were analysed. Parasites in the samples taken at 3 weeks carried only the asparagine mutant.
21
Darren R. Brooks, Ping Wang, Martin Read et al. · European Journal of Biochemistry · 1994 · 372 citations · Full text
Simon J. Foote, Denise Galatis, Alan F. Cowman · Proceedings of the National Academy of Sciences · 1990 · 307 citations
Léonardo K. Basco, Philippe Eldin de Pécoulas, Craig M. Wilson et al. · Molecular and Biochemical Parasitology · 1995 · 159 citations